Patents by Inventor Edward H. Kislauskis

Edward H. Kislauskis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8241592
    Abstract: Disclosed herein are apparatus and methods for isolating a fraction of interest from a physiological fluid sample. A sample holder for isolating a fraction of interest from a physiological fluid sample includes a flexible compartment and a rigid exoskeleton that supports the flexible compartment. The flexible compartment may have at least one reservoir with a height to volume ratio of about 0.1 cm/mL to about 5 cm/mL. An automated device for extracting a fraction of interest from the sample includes a sample holder with a flexible compartment supported by a rigid exoskeleton, a support for the sample holder connected to one or more fluid extraction devices, and a motor for moving the extraction device relative to the sample holder. The automated device may include an optical sensor and may include a clamp for clamping the flexible compartment.
    Type: Grant
    Filed: September 29, 2011
    Date of Patent: August 14, 2012
    Assignee: Endocellutions, Inc.
    Inventors: Neil F. Duffy, Jr., Jeffrey R. Chabot, Edward H. Kislauskis
  • Publication number: 20120021501
    Abstract: Disclosed herein are apparatus and methods for isolating a fraction of interest from a physiological fluid sample. A sample holder for isolating a fraction of interest from a physiological fluid sample includes a flexible compartment and a rigid exoskeleton that supports the flexible compartment. The flexible compartment may have at least one reservoir with a height to volume ratio of about 0.1 cm/mL to about 5 cm/mL. An automated device for extracting a fraction of interest from the sample includes a sample holder with a flexible compartment supported by a rigid exoskeleton, a support for the sample holder connected to one or more fluid extraction devices, and a motor for moving the extraction device relative to the sample holder. The automated device may include an optical sensor and may include a clamp for clamping the flexible compartment.
    Type: Application
    Filed: September 29, 2011
    Publication date: January 26, 2012
    Applicant: ECW Therapeutics, Inc.
    Inventors: Neil F. Duffy, JR., Jeffrey R. Chabot, Edward H. Kislauskis
  • Patent number: 8048678
    Abstract: Disclosed herein are apparatus and methods for isolating a fraction of interest from a physiological fluid sample. A sample holder for isolating a fraction of interest from a physiological fluid sample includes a flexible compartment and a rigid exoskeleton that supports the flexible compartment. The flexible compartment may have at least one reservoir with a height to volume ratio of about 0.1 cm/mL to about 5 cm/mL. An automated device for extracting a fraction of interest from the sample includes a sample holder with a flexible compartment supported by a rigid exoskeleton, a support for the sample holder connected to one or more fluid extraction devices, and a motor for moving the extraction device relative to the sample holder. The automated device may include an optical sensor and may include a clamp for clamping the flexible compartment.
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: November 1, 2011
    Assignee: ECW Therapeutics, Inc.
    Inventors: Neil F. Duffy, Jr., Jeffrey R. Chabot, Edward H Kislauskis
  • Publication number: 20110033925
    Abstract: Disclosed herein are apparatus and methods for isolating a fraction of interest from a physiological fluid sample.
    Type: Application
    Filed: June 29, 2010
    Publication date: February 10, 2011
    Inventors: Neil F. Duffy, JR., Jeffrey R. Chabot, Edward H. Kislauskis
  • Publication number: 20080267963
    Abstract: The invention relates to methods and reagents for immunizing and treating individual with cancer to elicit specific cellular and humoral immune-responses against specific cancer cell surface antigens, including those cancer cell surface antigens expressed only in cancer cells and in non-cancer cells normally located in one or more immune-privileged sites or tissues of the individual. The invention provides methods of using specifically prepared immunogen in fresh or lyophilized liposome, proper routes of administration of the immunogen, proper doses of the immunogen, and specific combinations of heterologous immunization including DNA priming in one administration route followed by liposome-mediated protein antigen boost in a different route to tailor the immune responses in respects of enhancing cell mediated immune response, cytokine secretion, humoral immune response, especially skewing T helper responses to be Th1 or a balanced Th1 and Th2 type.
    Type: Application
    Filed: October 27, 2005
    Publication date: October 30, 2008
    Applicant: Biomedical Research Model, Inc.
    Inventors: Edward H. Kislauskis, Kejian Yang, Barbara J. Whalen
  • Patent number: 5641675
    Abstract: Disclosed are the particular 3' noncoding nucleotide sequences (zipcode and zipcode elements) that cause .beta.-actin mRNA (and .beta.-actin protein synthesis) to be localized in specific regions of the cytoplasm. Also disclosed is the discovery that zipcode function can be fully inhibited by antisense oligonucleotides.
    Type: Grant
    Filed: October 7, 1994
    Date of Patent: June 24, 1997
    Assignee: University of Massachusetts Medical Center
    Inventors: Robert H. Singer, Edward H. Kislauskis